Targeting NANOG and FAK via Cx26-derived Cell-penetrating Peptides in Triple-negative Breast Cancer.
Mulkearns-Hubert EE, Esakov Rhoades E, Ben-Salem S, Bharti R, Hajdari N, Johnson S, Myers A, Smith IN, Bandyopadhyay S, Eng C, Downs E, Lathia JD, Reizes O.
Mulkearns-Hubert EE, et al. Among authors: bandyopadhyay s.
Mol Cancer Ther. 2024 Jan 3;23(1):56-67. doi: 10.1158/1535-7163.MCT-21-0783.
Mol Cancer Ther. 2024.
PMID: 37703580
Free PMC article.